|
 |
| AUTHORS' REPLY |
|
|
|
| Year : 2013 | Volume
: 45
| Issue : 3 | Page : 314 |
| |
Author's reply
Tanvir Samra
Dr. Ram Manohar Lohia Hospital, Baba Kharak Singh Marg, Connaught Place, New Delhi, India
| Date of Web Publication | 15-May-2013 |
Correspondence Address:
Tanvir Samra
Dr. Ram Manohar Lohia Hospital, Baba Kharak Singh Marg, Connaught Place, New Delhi
India
 Source of Support: None, Conflict of Interest: None  | Check |
How to cite this article:
Samra T. Author's reply. Indian J Pharmacol 2013;45:314 |
Sir,
I agree that there are different studies both for and against the chemoprophylactic intake of oseltamivir in health care personal (HCP) with different levels of exposure to H1N1 infection.
But in our study, we have included those HCP who were following all other infection control measures also, such as use of personal protective equipment (PPE), frequent handwashing, etc.
In such circumstances, the intake of oseltamivir does not give any added benefit.
Their is a need to carry out further studies for prophylactic intake of oseltamivir in other HCP who are at risk and are not using other infection control measures appropriately.
|
